NASDAQ: SABS - SAB Biotherapeutics, Inc.

छह महीने के लिए लाभप्रदता: -50%
भाग प्रतिफल: 0.00%
सेक्टर: Healthcare

पदोन्नति कार्यक्रम SAB Biotherapeutics, Inc.

उन्नत शेड्यूल सरल ग्राफ
Financial Markets by TradingView

कंपनी के बारे में SAB Biotherapeutics, Inc.

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at infectious diseases and immune and autoimmune disorders, including infectious diseases, influenza, CDI, type 1 diabetes, organ transplantation, and oncology, as well as immunology, gastroenterology, and respiratory diseases.

अधिक जानकारी
The company also uses its DiversitAb immunotherapy platform to produce fully-human polyclonal antibodies without the need for human donors or plasma. In addition, its lead product candidates include SAB-185, a fully-human polyclonal antibody therapeutic candidate that is in Phase III clinical trial for the treatment of COVID-19; and SAB-176, a fully-human polyclonal antibody therapeutic candidate that is in development for the treatment or prevention of severe influenza. Further, the company's pre-clinical product candidates in development for autoimmune diseases include SAB-142 for type 1 diabetes and organ transplant induction/rejection. SAB Biotherapeutics, Inc. was founded in 2014 and is headquartered in Sioux Falls, South Dakota.
तुलना सूची में जोड़ें
घड़ी सूची में जोड़ें
पोर्टफोलियो में जोड़ें
मूल्य सूचना जोड़ें

IPO date 2021-02-09
ISIN US78397T1034
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.sabbiotherapeutics.com
Цена ао 1.53
प्रति दिन मूल्य परिवर्तन: -0.7194% (1.39)
प्रति सप्ताह मूल्य परिवर्तन: +8.66% (1.27)
प्रति माह मूल्य परिवर्तन: -14.81% (1.62)
3 महीने में कीमत में बदलाव: -60.34% (3.48)
छह महीने में कीमत में बदलाव: -50% (2.76)
प्रति वर्ष मूल्य परिवर्तन: -70% (4.6)
3 वर्षों में मूल्य परिवर्तन: -47.13% (2.61)
वर्ष की शुरुआत से मूल्य परिवर्तन: -66.34% (4.0999)
सभी पैरामीटर

बहुत मूल्यवान समझना

नाम अर्थ श्रेणी
P/S 1.75 8
P/BV 0.0684 10
P/E 0 0
EV/EBITDA 1.36 10
कुल: 6

क्षमता

नाम अर्थ श्रेणी
ROA, % -50.27 0
ROE, % -73.64 0
कुल: 0

लाभांश

नाम अर्थ श्रेणी
Div yield, % 0 0
DSI 0 0
कुल: 0

कर्तव्य

नाम अर्थ श्रेणी
Debt/EBITDA -0.1721 10
कुल: 9.6

विकास का आवेग

नाम अर्थ श्रेणी
लाभप्रदता Revenue, % -34.15 0
लाभप्रदता Ebitda, % 365.04 10
लाभप्रदता EPS, % 3428.04 10
कुल: 8
अधिक जानकारी

संस्थानों आयतन शेयर करना, %
Marshall Wace LLP 4585282 49.7
RA Capital Management, L.P. 2374081 25.73
COMMODORE CAPITAL LP 1831746 19.86
RTW Investments LP 917828 9.95
BVF Inc. 917828 9.95
Sessa Capital IM, L.P. 458457 4.97
Vanguard Group Inc 99614 1.08
First Premier Bank 80754 0.88
Pathstone Holdings, LLC 50651 0.55
Geode Capital Management, LLC 35636 0.39



पर्यवेक्षक नौकरी का शीर्षक भुगतान जन्म का साल
Mr. Samuel J. Reich CEO & Executive Chairman 363.2k 1975 (50 साल)
Dr. Eddie Joe Sullivan Ph.D. Co-Founder, President & Director 402.56k 1966 (59 साल)
Ms. Christine E. Hamilton M.B.A. Co-Founder & Independent Director 25k 1956 (69 साल)
Dr. Alexandra Kropotova M.B.A., M.D. Executive VP & Chief Medical Officer 774.45k 1973 (52 वर्ष)
Dr. Edward D. Hamilton D.V.M. Co-Founder & Board Observer N/A
Dr. Christoph Bausch M.B.A., Ph.D. Executive VP & COO 443.2k 1971 (54 वर्ष)
Dr. Carlos N. Carillo Ph.D. Senior Vice President of Regulatory Affairs N/A
Mr. Mark W. Conley Interim Chief Financial Officer

पता: United States, Sioux Falls. SD, 2100 East 54th Street North - Google मानचित्र में खोलें, यांडेक्स मानचित्र खोलें
वेबसाइट: https://www.sabbiotherapeutics.com